The online version of this article (doi:10.1186/s12891-015-0762-4) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
GL conducted the literature search and reviewed articles for the analysis. AC participated in study design and coordination and reviewed articles for the analysis. ND conceived of the study and participated in its design and coordination. All authors contributed to drafting the manuscript. All authors read and approved the final manuscript.
Gout is a chronic disease of monosodium urate (MSU) crystal deposition. Although hyperuricaemia is the central risk factor for development of gout, not all people with hyperuricaemia have subclinical MSU crystal deposition or indeed, symptomatic disease. The aim of this systematic literature review was to identify factors that contribute to MSU crystallization.
A search was conducted of the electronic databases PubMed, Science Direct and Scopus. Articles were included if they contained original data related to MSU crystallization. The methods and results were summarized and categorized into articles describing at least one of the three key steps in MSU crystallization (reduced urate solubility, nucleation and growth).
A total of 2175 articles were initially identified in our systematic search with 35 of these articles included in the final analysis. Elevated urate concentration was identified as a central factor driving all three stages of MSU crystallization. Factors that were found to consistently reduce urate solubility were reduced temperatures, pH 7–9 and various ions including sodium ions. Connective tissue factors including bovine cartilage homogenates and healthy human synovial fluid and serum all enhanced urate solubility. MSU nucleation was found to be increased by a number of factors, including sodium ions, uric acid binding antibodies, and synovial fluid or serum from patients with gout. Other than elevated urate concentrations, no other specific factors were identified as promoters of MSU crystal growth.
Increased urate concentration is the key factor required at each stage of MSU crystallization. Different proteins and factors within connective tissues may promote MSU crystallization and may be important for determining the sites at which MSU crystallization occurs in the presence of elevated urate concentrations.
Additional file 1: Table S1. Summary of journal articles included in the review categorized by the relevant stage of crystallization. (DOCX 37 kb)12891_2015_762_MOESM1_ESM.docx
Pineda C, Amezcua-Guerra LM, Solano C, Rodriguez-Henriquez P, Hernandez-Diaz C, Vargas A, et al. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther. 2011;13:R4. doi: 10.1186/ar3223. CrossRefPubMedPubMedCentral
Dalbeth N, Aati O, Kalluru R, Gamble GD, Horne A, Doyle AJ, et al. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study. Ann Rheum Dis. 2014. doi: 10.1136/annrheumdis-2013-204273.
Mersmann A. Physical and chemical properties of crystalline systems. In: Mersmann A, editor. Crystallization technology handbook. 2nd ed. New York: Marcel Dekker, Inc.; 2001. p. 1–44. CrossRef
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339. doi: 10.1136/bmj.b2535
Silberberg MS. Solubility and molecular structure. Principles of general chemistry. 3rd ed. New York: McGraw-Hill Education; 2012.
Mullin JW. Nucleation of monosodium urate crystals. Crystallization. 4th ed. Oxford: Butterworth Heinemann; 2001.
Oliviero F, Scanu A, Punzi L. Metabolism of crystals within the joint. Reumatismo. 2011;63:221–9. doi: 10.4081/reumatismo.2011.221.
H-k T, Wilcox WR, Cooper SM. Crystallization of monosodium urate and calcium urate at 37° C. J Colloid Interface Sci. 1980;77:195–201. CrossRef
McGill NW, Dieppe PA. The role of serum and synovial fluid components in the promotion of urate crystal formation. J Rheumatol. 1991;18:1042–5. PubMed
Kam M, Perl-Treves D, Caspi D, Addadi L. Antibodies against crystals. FASEB J. 1992;6:2608–13. PubMed
Lang A, Hörler D, Baici A. The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol. 2000;27:1970–9. PubMed
- Factors influencing the crystallization of monosodium urate: a systematic literature review
- BioMed Central
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II